Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma

Radiotherapy and Oncology

Volumn 85, Issue 1, 2007, Pages 42-47

  Hoebers, Frank J P ^a   Heemsbergen, Wilma ^a   Balm, Alfons J M ^b,c   van Zanten, Mathilde ^a   Schornagel, Jan H ^b   Rasch, Coen R N ^a  

^a Department of Radiotherapy ^*  (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Chemoradiation; Cisplatin; Head and neck cancer; Radiotherapy

Indexed keywords

CISPLATIN;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUBE FEEDING; ADULT; AGED; CANCER STAGING; HEAD AND NECK TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATIENT COMPLIANCE;

ADULT; AGED; AGED, 80 AND OVER; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 35348899109     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.03.014     Document Type: Article

References (15)

1. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
2. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
3. Bourhis J, Amand, C, Pignon, J-P. on behalf of the MACH-NC Collaborative Group. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. J Clin Oncol 2004;22 No 14S (July 15 Suppl.): ASCO Annual Meeting Proceedings (Post-Meeting Edition) p. 5505.
4. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
5. Jeremic B., Milicic B., Dagovic A., Vaskovic Z., and Tadic L. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J Clin Oncol 22 (2004) 3540-3548
6. Bartelink H., van den Bogaert W., Horiot J.C., Jager J., and van Glabbeke M. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial. Eur J Cancer 38 (2002) 667-673
7. Balm A.J., Rasch C.R., Schornagel J.H., et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 26 (2004) 485-493
8. Buitelaar D.R., Balm A.J., Antonini N., van Tinteren H., and Huitink J.M. Cardiovascular and respiratory complications after major head and neck surgery. Head Neck 28 (2006) 595-602
9. Piccirillo J.F. Importance of comorbidity in head and neck cancer. Laryngoscope 110 (2000) 593-602
10. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
11. Wolters U., Wolf T., Stutzer H., and Schroder T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 77 (1996) 217-222
12. Ries F., and Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8 (1986) 368-379
13. van den Broek G.B., Rasch C.R., Pameijer F.A., et al. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer 101 (2004) 1809-1817
14. Baatenburg De Jong R.J., Hermans J., Molenaar J., Briaire J.J., and le Cessie S. Prediction of survival in patients with head and neck cancer. Head Neck 23 (2001) 718-724
15. Sobin LH, Wittekind CH. UICC TNM Classification of malignant tumors. 5th ed. New York: John Wiley & Sons, Inc.; 1997:2001.